ESR1 and carcinoma: Some investigators have postulated a dualistic model for the development of EAOC, in which the loss of ER expression marks a pivotal point in the carcinogenic pathway separating the development of estrogen-dependent carcinomas (i.e., endometrioid) from estrogen-independent carcinomas (i.e., clear cell) [85,86].